Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The First Year Matters: Lifestyle Behaviors and Five-Year Cardiometabolic Risk Factor Accumulation After Traumatic Brain Injury.

Medical sciences (Basel, Switzerland)·2026
Same author

The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro.

Endocrine·2026
Same author

Acetate Metabolism in Thyroid Cancer Progression.

International journal of molecular sciences·2026
Same author

Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications.

Journal of clinical medicine·2026
Same author

Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer.

The Journal of clinical endocrinology and metabolism·2026
Same author

Implantation of cancer cells from transoral endoscopic thyroidectomy: a case report.

Gland surgery·2026

Related Experiment Video

Updated: Aug 3, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Thyroid Metastasis from Primary Breast Cancer.

Armando Patrizio1, Silvia Martina Ferrari2, Giulio Stoppini2

  • 1Department of Emergency Medicine, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy.

Journal of Clinical Medicine
|April 13, 2023
PubMed
Summary

Thyroid metastasis from breast cancer is rare but can occur years later. Clinicians should consider this possibility in breast cancer patients with thyroid symptoms or lesions.

Keywords:
breast cancersecondary thyroid cancerthyroid metastasisthyroid ultrasound

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.2K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.4K

Related Experiment Videos

Last Updated: Aug 3, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.2K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.4K

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Breast cancer (BC) commonly metastasizes to bone, lungs, brain, and liver.
  • Thyroid gland metastasis (TM) from BC is a rare occurrence, even in advanced stages.

Purpose of the Study:

  • To review the literature on thyroid metastasis from breast cancer.
  • To highlight the importance of considering TM in BC follow-up care.

Main Methods:

  • Literature review of recent publications on TM from BC.
  • Case study of a patient with late-onset TM from BC.

Main Results:

  • Prevalence of TM in BC ranges from 3% to 34%.
  • Median onset time for TM is 48.2 months, with late occurrences not uncommon.
  • Thyroid surgery can help manage local disease burden in TM.

Conclusions:

  • TM from BC can present many years after primary diagnosis.
  • Clinicians should consider TM in BC patients with cervical symptoms or incidental thyroid findings.
  • Early diagnosis and consideration of surgical intervention can improve patient outcomes.